AlphaFold predicted structure
TCF20 · Q9UGU0

Mean pLDDT
38.9/ 100
Very low
1,960 residues
Confidence breakdown
- Very high(≥ 90)5%
- Confident(70–90)3%
- Low(50–70)3%
- Very low(< 50)90%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transcription factor 20
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinteddevelopmental delay with variable intellectual impairment and behavioral abnormalities
Intellectual disability
Neurodevelopmental abnormality
hereditary disease
Developmental delay with variable intellectual impairment and behavioural abnormalities
Neurodevelopmental delay
Global developmental delay
autism
Mild intellectual disability
Generalized hypotonia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transcription factor 20
Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator
TCF20 · Q9UGU0

Mean pLDDT
38.9/ 100
Very low
1,960 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0